296 related articles for article (PubMed ID: 7609566)
1. Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations.
Jobes DR; Aitken GL; Shaffer GW
J Thorac Cardiovasc Surg; 1995 Jul; 110(1):36-45. PubMed ID: 7609566
[TBL] [Abstract][Full Text] [Related]
2. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
[TBL] [Abstract][Full Text] [Related]
3. Heparin and protamine titration do not improve haemostasis in cardiac surgical patients.
Shore-Lesserson L; Reich DL; DePerio M
Can J Anaesth; 1998 Jan; 45(1):10-8. PubMed ID: 9466020
[TBL] [Abstract][Full Text] [Related]
4. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C
J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
[TBL] [Abstract][Full Text] [Related]
5. Heparinase thromboelastography compared with activated coagulation time for protamine titration after cardiopulmonary bypass.
Levin AI; Heine AM; Coetzee JF; Coetzee A
J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):224-9. PubMed ID: 24461364
[TBL] [Abstract][Full Text] [Related]
6. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
Meesters MI; Veerhoek D; de Lange F; de Vries JW; de Jong JR; Romijn JW; Kelchtermans H; Huskens D; van der Steeg R; Thomas PW; Burtman DT; van Barneveld LJ; Vonk AB; Boer C
Thromb Haemost; 2016 Aug; 116(2):251-61. PubMed ID: 27277211
[TBL] [Abstract][Full Text] [Related]
7. Protamine dosage based on two titrations reduces blood loss after valve replacement surgery: a prospective, double-blinded, randomized study.
Guo Y; Tang J; Du L; Liu J; Liu RC; Liu X; Guo Y
Can J Cardiol; 2012; 28(5):547-52. PubMed ID: 22633184
[TBL] [Abstract][Full Text] [Related]
8. Management of postoperative heparin rebound following cardiopulmonary bypass.
Pifarré R; Babka R; Sullivan HJ; Montoya A; Bakhos M; El-Etr A
J Thorac Cardiovasc Surg; 1981 Mar; 81(3):378-81. PubMed ID: 7464201
[TBL] [Abstract][Full Text] [Related]
9. Calculation Algorithm Reduces Protamine Doses Without Increasing Blood Loss or the Transfusion Rate in Cardiac Surgery: Results of a Randomized Controlled Trial.
Kjellberg G; Holm M; Fux T; Lindvall G; van der Linden J
J Cardiothorac Vasc Anesth; 2019 Apr; 33(4):985-992. PubMed ID: 30206011
[TBL] [Abstract][Full Text] [Related]
10. Safety issues in heparin and protamine administration for extracorporeal circulation.
Jobes DR
J Cardiothorac Vasc Anesth; 1998 Apr; 12(2 Suppl 1):17-20. PubMed ID: 9583571
[TBL] [Abstract][Full Text] [Related]
11. An Adjusted Calculation Model Allows for Reduced Protamine Doses without Increasing Blood Loss in Cardiac Surgery.
Kjellberg G; Sartipy U; van der Linden J; Nissborg E; Lindvall G
Thorac Cardiovasc Surg; 2016 Sep; 64(6):487-93. PubMed ID: 26270199
[TBL] [Abstract][Full Text] [Related]
12. The Hemochron Response RxDx heparin and protamine dosing system.
Jaryno SA; Zucker ML; LaDuca FM
J Extra Corpor Technol; 2004 Sep; 36(3):258-62. PubMed ID: 15559745
[TBL] [Abstract][Full Text] [Related]
13. Low-dose protamine based on heparin-protamine titration method reduces platelet dysfunction after cardiopulmonary bypass.
Shigeta O; Kojima H; Hiramatsu Y; Jikuya T; Terada Y; Atsumi N; Sakakibara Y; Nagasawa T; Mitsui T
J Thorac Cardiovasc Surg; 1999 Aug; 118(2):354-60. PubMed ID: 10425010
[TBL] [Abstract][Full Text] [Related]
14. The effect of protamine dosing variation on bleeding and transfusion after heparinisation for cardiopulmonary bypass.
Kunz SA; Miles LF; Ianno DJ; Mirowska-Allen KL; Matalanis G; Bellomo R; Seevanayagam S
Perfusion; 2018 Sep; 33(6):445-452. PubMed ID: 29544405
[TBL] [Abstract][Full Text] [Related]
15. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
[TBL] [Abstract][Full Text] [Related]
16. Comparison of two protocols for heparin neutralization by protamine after cardiopulmonary bypass.
Arén C; Feddersen K; Rådegran K
J Thorac Cardiovasc Surg; 1987 Oct; 94(4):539-41. PubMed ID: 3309479
[TBL] [Abstract][Full Text] [Related]
17. Optimal protamine dosing after cardiopulmonary bypass: The PRODOSE adaptive randomised controlled trial.
Miles LF; Burt C; Arrowsmith J; McKie MA; Villar SS; Govender P; Shaylor R; Tan Z; De Silva R; Falter F
PLoS Med; 2021 Jun; 18(6):e1003658. PubMed ID: 34097705
[TBL] [Abstract][Full Text] [Related]
18. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
[TBL] [Abstract][Full Text] [Related]
19. An Adjusted Calculation Model of Reduced Heparin Doses in Cardiopulmonary Bypass Surgery in a Chinese Population.
Zhang Y; Liu K; Li W; Xue Q; Hong J; Xu J; Wu L; Ji G; Sheng J; Wang Z
J Cardiothorac Vasc Anesth; 2016 Oct; 30(5):1179-83. PubMed ID: 27475733
[TBL] [Abstract][Full Text] [Related]
20. A four-year experience with patient individualized heparin and protamine dosing using the Hemochron RxDx system.
Bennett KM; Briggins D; Zucker M; LaDuca F
J Extra Corpor Technol; 2001 Feb; 33(1):19-22. PubMed ID: 11315128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
